Search - Prime Therapeutics

388 Results for GLP-1 Pipeline Update

Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Press Releases
Star Tribune: Most patients quit GLP-1 drugs in two years, jeopardizing their weight loss

Star Tribune

PA Sub-Categories: GLP-1 Prime Article: In the News
Managing the mad rush on GLP-1s: How to prioritize patients who have on-label prescriptions for diabetes therapy

Shortages in the manufacturing chain have led to label hopping and an increase in off-label use

PA Sub-Categories: GLP-1 Prime Article: Perspectives
The evolution of GLP-1s

publications The evolution of GLP-1s September 1, 2024 Prime's clinical experts share their perspectives on developing a holistic, individualized strategy to capitalize on opportunities and...